The evolutionary mechanism of cancer

Journal of Cellular Biochemistry

Volumn 109, Issue 6, 2010, Pages 1072-1084

  Heng, Henry H Q ^a   Stevens, Joshua B ^a   Bremer, Steven W ^a   Ye, Karen J ^b   Liu, Guo ^a   Ye, Christine J ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SeeDNA Biotech Inc   (Canada)

Author keywords

Cancer evolutionary mechanism; Genome theory; Genomic instability; Macro evolution; Non Clonal Chromosome Aberrations (NCCAs)

Indexed keywords

CANCER RESEARCH; CARCINOGENESIS; CHROMOSOME ABERRATION; GENE MUTATION; GENOME; GENOMIC INSTABILITY; HUMAN; MOLECULAR EVOLUTION; NEOPLASM; PRIORITY JOURNAL; REVIEW; SOMATIC CELL;

ANIMALS; CHROMOSOME ABERRATIONS; EVOLUTION, MOLECULAR; GENOMIC INSTABILITY; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS;

EID: 77951734539     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22497     Document Type: Review

References (105)

1. Ao P. 2009. Global view of bionetwork dynamics: Adaptive landscape. J Genet Genomics 36:63-73.
2. Armtage P, Doll R. 1954. The age distribution of cancer and a multi-stage theory of carcinogenesis. Br J Cancer 8:1-12.
3. Aubele M, Mattis A, Zitzelsberger H, Walch A, Kremer M, Hutzler P, Höfler H, Werner M. 1999. Intratumoral heterogeneity in breast carcinoma revealed by laser-microdissection and comparative genomic hybridization. Cancer Genet Cytogenet 110:94-102. (Pubitemid 29181514)
4. Barabási AL. 2003. Linked: How everything is connected to everything else and what it mean for business, science and everyday life. Plume. Cambridge, Massachusetts.
5. Bartos JD, Gaile DP, McQuaid DE, Conroy JM, Darbary H, Nowak NJ, Block A, Petrelli NJ, Mittelman A, Stoler DL, Anderson GR. 2007. aCGH local copy number aberrations associated with overall copy number genomic instability in colorectal cancer: Coordinate involvement of the regions including BCR and ABL. Mutat Res 615:1-11. (Pubitemid 46054087)
6. Bayani J, Selvarajah S, Maire G, Vukovic B, Al-Romaih K, Zielenska M, Squire JA. 2007. Genomic mechanisms and measurement of structural and numerical instability in cancer cells. Semin Cancer Biol 17:5-18.
7. Baylin SB. 2005. DNA methylation and gene silencing in cancer. Nat Clin Pract Oncol 1:S4-S11.
8. Beerenwinkel N, Antal T, Dingli D, Traulsen A, Kinzler KW, Velculescu VE, Vogelstein B, Nowak MA. 2007. Genetic progression and the waiting time to cancer. PLoS Comput Biol 3:e225.
9. Bielas JH, Loeb KR, Rubin BP, True LD, Loeb LA. 2006. Human cancers express a mutator phenotype. Proc Natl Acad Sci USA 103:18238-18242.
10. Bissell MJ, Kenny PA, Radisky DC. 2005. Microenvironmental regulators of tissue structure and function also regulate tumor induction and progression: The role of extracellular matrix and its degrading enzymes. Cold Spring Harb Symp Quant Biol 70:343-356.
11. Brentnall TA, Brentnall TA, Crispin DA, Rabinovitch PS, Haggitt RC, Rubin CE, Stevens AC, Burmer GC. 1994. Mutations in the p53 gene: An early marker of neoplastic progression in ulcerative colitis. Gastroenterology 107:369-378.
12. Brock A, Chang H, Huang S. 2009. Non-genetic heterogeneity-A mutation-independent driving force for the somatic evolution of tumours. Nat Rev Genet 10:336-342.
13. Cahill DP, Kinzler KW, Vogelstein B, Lengauer C. 1999. Genetic instability and Darwinian selection in tumours. Trends Cell Biol 9:M57-M60.
14. Cairns J. 1975. Mutation selection and the natural history of cancer. Nature 255:197-200.
15. Coffey DS. 1998. Self-organization, complexity and chaos: The new biology for medicine. Nat Med 4:882-885. (Pubitemid 28364016)
16. Collins FS, Barker AD. 2007. Mapping the cancer genome. Pinpointing the genes involved in cancer will help chart a new course across the complex landscape of human malignancies. Sci Am 296:50-57.
17. Crespi B, Summers K. 2005. Evolutionary biology of cancer. Trends Ecol Evol 20:545-552.
18. de Grouchy J, de Nava C, Cantu JM, Bilski-Pasquier G, Bousser J. 1966. Models for clonal evolutions: A study of chronic myelogenous leukemia. Am J Hum Genet 18:485-503.
19. Delcuve GP, Rastegar M, Davie JR. 2009. Epigenetic control. J Cell Physiol 219:243-250.
20. Dexter DL, Kowalski HM, Blazar BA, Fligiel Z, Vogel R, Heppner GH. 1978. Heterogeneity of tumor cells from a single mouse mammary tumor. Cancer Res 38:3174-3181. (Pubitemid 9031291)
21. Dolinoy DC, Jirtle RL. 2008. Environmental epigenomics in human health and disease. Environ Mol Mutagen 49:4-8. (Pubitemid 351293007)
22. Duesberg P, Stindl R, Hehlmann R. 2000. Explaining the high mutation rates of cancer cells to drug and multidrug resistance by chromosome reassortments that are catalyzed by aneuploidy. Proc Natl Acad Sci USA 97:14295-14300. (Pubitemid 32036702)
23. Duesberg P, Li R, Fabarius A, Hehlmann R. 2006. Aneuploidy and cancer: From correlation to causation. Contrib Microbiol 13:16-44.
24. Esteller M. 2008. Epigenetics in cancer. N Engl J Med 358:1148-1159.
25. Fan JB, Chee MS, Gunderson KL. 2006. Highly parallel genomic assays. Nat Rev Genet 7:632-644.
26. Feinberg AP, Ohlsson R, Henikoff S. 2006. The epigenetic progenitor origin of human cancer. Nat Rev Genet 7:21-32. (Pubitemid 41828945)
27. Feuk L, Carson AR, Scherer SW. 2006. Structural variation in the human genome. Nat Rev Genet 7:85-97.
28. Foulds L. 1954. The experimental study of tumor progression: A review. Can Res 14:327-399.
29. Gatenby RA. 2009. A change of strategy in the war on cancer. Nature 459:508-509.
30. Gell-Mann M. 1994. The quark and the jaguar: Adventures in the simple and the complex. San Francisco: W.H. Freeman.
31. Gerhart J, Kirschner M. 2007. The theory of facilitated variation. Proc Natl Acad Sci USA 1:8582-8589.
32. Glansdorff N, Xu Y, Labedan B. 2009. The conflict between horizontal gene transfer and the safeguard of identity: Origin of meiotic sexuality. J Mol Evol 69:470-480.
33. Goh KI, Cusick ME, Valle D, Childs B, Vidal M, Barabási AL. 2007. The human disease network. Proc Natl Acad Sci USA 104:8685-8690.
34. Gonzalez-Garcia I, Sole RV, Costa J. 2002. Metapopulation dynamics and spatial heterogeneity in cancer. Proc Natl Acad Sci USA 99:13085-13089.
35. Gorelick R, Carpinone J. 2009. Origin and maintenance of sex: The evolutionary joys of self sex. Biol J Linnaean Soc 98:707-728.
36. Gould SJ, Eldredge N. 1993. Punctuated equilibrium comes of age. Nature 366:223-227.
37. Greaves M. 2006. Infection, immune responses and the aetiology of childhood leukaemia. Nat Rev Cancer 6:193-203. (Pubitemid 43292563)
38. Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, Bignell G, Davies H, Teague J, Butler A, Stevens C, Edkins S, O'Meara S, Vastrik I, Schmidt EE, Avis T, Barthorpe S, Bhamra G, Buck G, Choudhury B, Clements J, Cole J, Dicks E, Forbes S, Gray K, Halliday K, Harrison R, Hills K, Hinton J, Jenkinson A, Jones D, Menzies A, Mironenko T, Perry J, Raine K, Richardson D, Shepherd R, Small A, Tofts C, Varian J, Webb T, West S, Widaa S, Yates A, Cahill DP, Louis DN, Goldstraw P, Nicholson AG, Brasseur F, Looijenga L, Weber BL, Chiew YE, DeFazio A, Greaves MF, Green AR, Campbell P, Birney E, Easton DF, Chenevix-Trench G, Tan MH, Khoo SK, Teh BT, Yuen ST, Leung SY, Wooster R, Futreal PA, Stratton MR. 2007. Patterns of somatic mutation in human cancer genome. Nature 446:153-158. (Pubitemid 46398669)
39. Hahn WC, Weinberg RA. 2002. Modeling the molecular circuitry of cancer. Nat Rev Cancer 2:331-341.
40. Hanahan D, Weinberg RA. 2000. The hallmarks of cancer. Cell 100:57-70.
41. Harris H. 2005. A long view of fashions in cancer research. BioEssays 27:833-838. (Pubitemid 41297405)
42. Heng HH. 2007a. Cancer genome sequencing: The challenges ahead. BioEssays 29:783-794.
43. Heng HH. 2007b. Elimination of altered karyotypes by sexual reproduction preserves species identity. Genome 50:517-524.
44. Heng HH. 2008a. The gene-centric concept: A new liability? BioEssays 30: 196-197.
45. Heng HH. 2008b. The conflict between complex system and reductionism. J Am Med Assoc 300:1580-1581.
46. Heng HH. 2009. The genome-centric concept: Re-synthesis of evolutionary theory. BioEssays 31:512-525.
47. Heng H, Chen WY, Wang YC. 1988. Effects of pingyanymycin on chromosomes: A possible structural basis for chromosome aberration. Mutat Res 199:199-205.
48. Heng HH, Squire J, Tsui LC. 1992. High-resolution mapping of mammalian genes by in situ hybridization to free chromatin. Proc Natl Acad Sci USA 89:9509-9513.
49. Heng HH, Chamberlain JW, Shi XM, Spyropoulos B, Tsui LC, Moens PB. 1996. Regulation of meiotic chromatin loop size by chromosomal position. Proc Natl Acad Sci USA 93(7):2795-2800. (Pubitemid 26114326)
50. Heng HH, Liu G, Lu W, Bremer S, Ye CJ, Hughes M, Moens P. 2001. Spectral karyotyping (SKY) of mouse meiotic chromosomes. Genome 44:293-298. (Pubitemid 32333544)
51. Heng HH, Ye CJ, Yang F, Ebrahim S, Liu G, Bremer SW, Thomas CM, Ye J, Chen TJ, Tuck-Muller C, Yu JW, Krawetz SA, Johnson A. 2003. Analysis of marker or complex chromosomal rearrangements present in pre- and post-natal karyotypes utilizing a combination of G-banding, spectral karyotyping and fluorescence in situ hybridization. Clin Genet 63:358-367. (Pubitemid 36944078)
52. Heng HH, Stevens JB, Liu G, Bremer SW, Ye CJ. 2004a. Imaging genome abnormalities in cancer research. Cell Chromosome 3:1.
53. Heng HH, Goetze S, Ye CJ, Liu G, Stevens JB, Bremer SW, Wykes SM, Bode J, Krawetz SA. 2004b. Chromatin loops are selectively anchored using scaffold/matrix-attachment regions. J Cell Sci 117:999-1008.
54. Heng HH, Liu G, Bremer S, Ye KJ, Stevens J, Ye CJ. 2006a. Clonal and nonclonal chromosome aberrations and genome variation and aberration. Genome 49:195-204. (Pubitemid 43979153)
55. Heng HH, Stevens JB, Liu G, Bremer SW, Ye KJ, Reddy PV, Wu GS, Wang YA, Tainsky MA, Ye CJ. 2006b. Stochastic cancer progression driven by nonclonal chromosome aberrations. J Cell Physiol 208:461-472. (Pubitemid 43993437)
56. Heng HH, Bremer SW, Stevens J, Ye KJ, Miller F, Liu G, Ye CJ. 2006c. Cancer progression by non-clonal chromosome aberrations. J Cell Biochem 98: 1424-1435.
57. Heng HH, Stevens JB, Lawrenson L, Liu G, Ye KJ, Bremer SW, Ye CJ. 2008. Patterns of genome dynamics and cancer evolution. Cell Oncol 30:513-514.
58. Heng HH, Bremer SW, Stevens JB, Ye KJ, Liu G, Ye CJ. 2009. Genetic and epigenetic heterogeneity in cancer: A genome-centric perspective. J Cell Physiol 220:538-547.
59. Heng HH, Liu G, Stevens J, Bremer S, Ye KJ, Zhang KZ, Wu GS, Shekhar MP, Wei WZ, Ye CJ. 2010. Molecular targeting leads to the macro-evolution of genome systems (Submitted).
60. Heppner GH. 1984. Tumor heterogeneity. Cancer Res 44:2259-2265.
61. Heppner GH, Miller FR. 1998. The cellular basis of tumor progression. Int Rev Cytol 177:1-56.
62. Holland JH. 1992. Adaptation in natural and artificial systems: An introductory analysis with applications to biology, control, and artificial intelligence. Cambridge, MA: MIT Press.
63. Huang S. 2002. Histone methyltransferases, diet nutrients and tumor suppressors. Nat Rev Cancer 2:469-476. (Pubitemid 37328944)
64. Jaffe LF. 2005. A calcium-based theory of carcinogenesis. Adv Cancer Res 94:231-263.
65. Jones RG, Thompson CB. 2009. Tumor suppressors and cell metabolism: A recipe for cancer growth. Genes Dev 23:537-548.
66. Jones PA, Archer TK, Baylin SB, Beck S, Berger S, Bernstein BE, Carpten JD, Clark SJ, Costello JF, Doerge RW, Esteller M, Feinberg AP, Gingeras TR, Greally JM, Henikoff S, Herman JG, Jackson-Grusby L, Jenuwein T, Jirtle RL, Kim YJ, Laird PW, Lim B, Martienssen R, Polyak K, Stunnenberg H, Tlsty TD, Tycko B, Ushijima T, Zhu J, Pirrotta V, Allis CD, Elgin SC, Jones PA, Martienssen R, Rine J, Wu C (American Association for Cancer Research Human Epigenome Task Force; European Union, Network of Excellence, Scientific Advisory Board). 2008a. Moving AHEAD with an international human epigenome project. Nature 454:711-715.
67. Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Kamiyama H, Jimeno A, Hong SM, Fu B, Lin MT, Calhoun ES, Kamiyama M, Walter K, Nikolskaya T, Nikolsky Y, Hartigan J, Smith DR, Hidalgo M, Leach SD, Klein AP, Jaffee EM, Goggins M, Maitra A, Iacobuzio-Donahue C, Eshleman JR, Kern SE, Hruban RH, Karchin R, Papadopoulos N, Parmigiani G, Vogelstein B, Velculescu VE, Kinzler KW. 2008b. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321:1801-1806.
68. Kauffman S. 1995. At home in the universe. The search for the laws of self-organization and complexity. New York, NY: Oxford University Press.
69. Ke XS, Qu Y, Rostad K, Li WC, Lin B, Halvorsen OJ, Haukaas SA, Jonassen I, Petersen K, Goldfinger N, Rotter V, Akslen LA, Oyan AM, Kalland KH. 2009. Genome-wide profiling of histone h3 lysine 4 and lysine 27 trimethylation reveals an epigenetic signature in prostate carcinogenesis. PLoS One 4(3): e4687.
70. Klein G, Klein E. 2005. Surveillance against tumors - Is it mainly immunological? Immunology 100:29-33.
71. Knudson AG, Jr. 1971. Mutation and cancer: Statistical study of retinoblastoma. Proc Natl Acad Sci USA 68:820-823.
72. Krizhanovsky V, Xue W, Zender L, Yon M, Hernando E, Lowe SW. 2008. Implications of cellular senescence in tissue damage response, tumor suppression, and stem cell biology. Cold Spring Harb Symp Quant Biol 73:513-522.
73. Lacoste S, Wiechec E, Dos Santos Silva AG, Guffei A, Williams G, Lowbeer M, Benedek K, Henriksson M, Klein G, Mai S. 2009. Chromosomal rearrangements after ex vivo Epstein-Barr virus (EBV) infection of human B cells. Oncogene 29:503-515.
74. Ley TJ, Mardis ER, Ding L, Fulton B, McLellan MD, Chen K, Dooling D, Dunford-Shore BH, McGrath S, Hickenbotham M, Cook L, Abbott R, Larson DE, Koboldt DC, Pohl C, Smith S, Hawkins A, Abbott S, Locke D, Hillier LW, Miner T, Fulton L, Magrini V, Wylie T, Glasscock J, Conyers J, Sander N, Shi X, Osborne JR, Minx P, Gordon D, Chinwalla A, Zhao Y, Ries RE, Payton JE, Westervelt P, Tomasson MH, Watson M, Baty J, Ivanovich J, Heath S, Shannon WD, Nagarajan R, Walter MJ, Link DC, Graubert TA, DiPersio JF, Wilson RK. 2008. DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature 456:66-72.
75. Liu ET. 2004. Expression genomics and cancer biology. Pharmacogenomics 5:1117-1128.
76. Maley CC, Galipeau PC, Finley JC, Wongsurawat VJ, Li X, Sanchez CA, Paulson TG, Blount PL, Risques RA, Rabinovitch PS, Reid BJ. 2006. Genetic clonal diversity predicts progression to esophageal adenocarcinoma. Nat Genet 38:468-473.
77. Manchester KL. 1995. Theodor Boveri and the origin of malignant tumours. Trends Cell Biol 5:384-387.
78. Mantovani A, Allavena P, Sica A, Balkwill F. 2008. Cancer-related inflammation. Nature 454:436-444.
79. Martien S, Abbadie C. 2007. Acquisition of oxidative DNA damage during senescence: The first step toward carcinogenesis? Ann N Y Acad Sci 1119:51-63.
80. Merlo LM, Pepper JW, Reid BJ, Maley CC. 2006. Cancer as an evolutionary and ecological process. Nat Rev Cancer 6:924-935.
81. Miasari M, Puthalakath H, Silke J. 2008. Ubiquitylation and cancer development. Curr Cancer Drug Targets 8:118-123.
82. Moenner M, Pluquet O, Bouchecareilh M, Chevet E. 2007. Integrated endoplasmic reticulum stress responses in cancer. Cancer Res 67:10631-10634. (Pubitemid 350145884)
83. Nelson CM, Bissell MJ. 2006. Of extracellular matrix, scaffolds, and signaling: Tissue architecture regulates development, homeostasis, and cancer. Annu Rev Cell Dev Biol 22:287-309.
84. Nowak MA, Michor F, Iwasa Y. 2006. Genetic instability and clonal expansion. J Theor Biol 241:26-32.
85. Nowell PC. 1976. The clonal evolution of tumor cell populations. Science 194:23-28.
86. Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Siu IM, Gallia GL, Olivi A, McLendon R, Rasheed BA, Keir S, Nikolskaya T, Nikolsky Y, Busam DA, Tekleab H, Diaz LA, Jr., Hartigan J, Smith DR, Strausberg RL, Marie SK, Shinjo SM, Yan H, Riggins GJ, Bigner DD, Karchin R, Papadopoulos N, Parmigiani G, Vogelstein B, Velculescu VE, Kinzler KW. 2008. An integrated genomic analysis of human glioblastoma multiforme. Science 321:1807-1812.
87. Quaranta V, Rejniak KA, Gerlee P, Anderson AR. 2008. Invasion emerges from cancer cell adaptation to competitive microenvironments: Quantitative predictions from multiscale mathematical models. Semin Cancer Biol 18:338-348.
88. Radisky DC, Levy DD, Littlepage LE, Liu H, Nelson CM, Fata JE, Leake D, Godden EL, Albertson DG, Nieto MA, Werb Z, Bissell MJ. 2005. Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature 436:123-127. (Pubitemid 40966197)
89. Rubin H. 2006. What keeps cells in tissues behaving normally in the face of myriad mutations? BioEssays 28:515-524.
90. Schatton T, Frank NY, Frank MH. 2009. Identification and targeting of cancer stem cells. BioEssays 31:1038-1049.
91. Sharp PA. 2009. The centrality of RNA. Cell 136:577-580.
92. Shen KC, Heng H, Wang Y, Lu S, Liu G, Deng CX, Brooks SC, Wang YA. 2005. ATM and p21 cooperate to suppress aneuploidy and subsequent tumor development. Cancer Res 65:8747-8753. (Pubitemid 41377363)
93. Stevens JB, Liu G, Bremer SW, Ye KJ, Xu W, Xu J, Sun Y, Wu GS, Savasan S, Krawetz SA, Ye CJ, Heng HH. 2007. Mitotic cell death by chromosome fragmentation. Cancer Res 67:7686-7694. (Pubitemid 47281361)
94. Tsao JL, Yatabe Y, Salovaara R, Järvinen HJ, Mecklin JP, Aaltonen LA, Tavaré S, Shibata D. 2000. Genetic reconstruction of individual colorectal tumor histories. Proc Natl Acad Sci USA 97:1236-1241. (Pubitemid 30080842)
95. Vincent TL, Brown JS. 2005. Evolutionary game theory, natural selection, and Darwinian dynamics. Cambridge, UK: Cambridge University Press.
96. Vogelstein B, Kinzler KW. 2004. Cancer genes and the pathways they control. Nat Med 10:789-799. (Pubitemid 39070849)
97. Wilkins AS, Holliday R. 2009. The evolution of meiosis from mitosis. Genetics 181:3-12.
98. Wood LD, Parsons DW, Jones S, Lin J, Sjöblom T, Leary RJ, Shen D, Boca SM, Barber T, Ptak J, Silliman N, Szabo S, Dezso Z, Ustyanksky V, Nikolskaya T, Nikolsky Y, Karchin R, Wilson PA, Kaminker JS, Zhang Z, Croshaw R, Willis J, Dawson D, Shipitsin M, Willson JK, Sukumar S, Polyak K, Park BH, Pethiyagoda CL, Pant PV, Ballinger DG, Sparks AB, Hartigan J, Smith DR, Suh E, Papadopoulos N, Buckhaults P, Markowitz SD, Parmigiani G, Kinzler KW, Velculescu VE, Vogelstein B. 2007. The genomic landscapes of human breast and colorectal cancers. Science 318:1108-1113. (Pubitemid 350134889)
99. Wu Y, Zhou BP. 2009. Inflammation: A driving force speeds cancer metastasis. Cell Cycle 8:3267-3273.
100. Ye CJ, Lu W, Liu G, Bremer SW, Wang YA, Moens P, Hughes M, Krawetz SA, Heng HH. 2001. The combination of SKY and specific loci detection with FISH or immunostaining. Cytogenet Cell Genet 93:195-202. (Pubitemid 32799804)
101. Ye CJ, Stevens JB, Liu G, Ye KJ, Yang F, Bremer SW, Heng HH. 2006. Combined multicolor-FISH and immunostaining. Cytogenet Genome Res 114:227-234.
102. Ye CJ, Liu G, Bremer SW, Heng HH. 2007. The dynamics of cancer chromosomes and genomes. Cytogenet Genome Res 118:237-246.
103. Ye CJ, Stevens JB, Liu G, Bremer SW, Jaiswal AS, Ye KJ, Lin MF, Lawrenson L, Lancaster WD, Kurkinen M, Liao JD, Gairola CG, Shekhar MP, Narayan S, Miller FR, Heng HH. 2009. Genome based cell population heterogeneity promotes tumorigenicity: The evolutionary mechanism of cancer. J Cell Physiol 219:288-300.
104. Yosida TH. 1966. Relation between chromosomal alteration and development of tumors. Jpn J Genet 41:439-451.
105. Zaidi SK, Young DW, Javed A, Pratap J, MontecinoM, van Wijnen A, Lian JB, Stein JL, Stein GS. 2007. Nuclear microenvironments in biological control and cancer. Nat Rev Cancer 7:454-463. (Pubitemid 46809169)